These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 32511396)

  • 1. IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity.
    Ejemel M; Li Q; Hou S; Schiller ZA; Wallace AL; Amcheslavsky A; Yilmaz NK; Toomey JR; Schneider R; Close BJ; Chen DY; Conway HL; Mohsan S; Cavacini LA; Klempner MS; Schiffer CA; Wang Y
    bioRxiv; 2020 May; ():. PubMed ID: 32511396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.
    Ejemel M; Li Q; Hou S; Schiller ZA; Tree JA; Wallace A; Amcheslavsky A; Kurt Yilmaz N; Buttigieg KR; Elmore MJ; Godwin K; Coombes N; Toomey JR; Schneider R; Ramchetty AS; Close BJ; Chen DY; Conway HL; Saeed M; Ganesa C; Carroll MW; Cavacini LA; Klempner MS; Schiffer CA; Wang Y
    Nat Commun; 2020 Aug; 11(1):4198. PubMed ID: 32826914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19.
    Varadhachary A; Chatterjee D; Garza J; Garr RP; Foley C; Letkeman A; Dean J; Haug D; Breeze J; Traylor R; Malek A; Nath R; Linbeck L
    medRxiv; 2020 Aug; ():. PubMed ID: 32817976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection.
    Seo SH; Jang Y
    Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33022950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
    Chatterjee SK; Saha S; Munoz MNM
    Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein.
    Joyce MG; Sankhala RS; Chen WH; Choe M; Bai H; Hajduczki A; Yan L; Sterling SL; Peterson CE; Green EC; Smith C; de Val N; Amare M; Scott P; Laing ED; Broder CC; Rolland M; Michael NL; Modjarrad K
    bioRxiv; 2020 Mar; ():. PubMed ID: 32511298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An
    Ortega JT; Serrano ML; Pujol FH; Rangel HR
    EXCLI J; 2020; 19():410-417. PubMed ID: 32210742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
    Hati S; Bhattacharyya S
    ACS Omega; 2020 Jul; 5(26):16292-16298. PubMed ID: 32656452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine.
    Ismail S; Ahmad S; Azam SS
    J Mol Liq; 2020 Sep; 314():113612. PubMed ID: 32834259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients.
    Caselli E; Soffritti I; Lamberti G; D'Accolti M; Franco F; Demaria D; Contoli M; Passaro A; Contini C; Perri P
    Biology (Basel); 2020 Nov; 9(11):. PubMed ID: 33153065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2.
    Nielsen SCA; Yang F; Jackson KJL; Hoh RA; Röltgen K; Stevens B; Lee JY; Rustagi A; Rogers AJ; Powell AE; Najeeb J; Otrelo-Cardoso AR; Yost KE; Daniel B; Chang HY; Satpathy AT; Jardetzky TS; Kim PS; Wang TT; Pinsky BA; Blish CA; Boyd SD
    bioRxiv; 2020 Jul; ():. PubMed ID: 32676593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2.
    Lee SH; Jee SW; Hwang DY; Kang JK
    Lab Anim Res; 2020; 36():23. PubMed ID: 32733785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K18-hACE2 Mice for Studies of COVID-19 Treatments and Pathogenesis Including Anosmia.
    Zheng J; Roy Wong LY; Li K; Verma AK; Ortiz M; Wohlford-Lenane C; Leidinger MR; Knudson CM; Meyerholz DK; McCray PB; Perlman S
    bioRxiv; 2020 Aug; ():. PubMed ID: 32817939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus.
    Suvorov A; Gupalova T; Desheva Y; Kramskaya T; Bormotova E; Koroleva I; Kopteva O; Leontieva G
    Front Pharmacol; 2021; 12():807256. PubMed ID: 35145407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-clays as Potential Pseudo-antibodies for COVID-19.
    Abduljauwad SN; Habib T; Ahmed HU
    Nanoscale Res Lett; 2020 Aug; 15(1):173. PubMed ID: 32857226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Publisher Correction: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.
    Huang Q; Ji K; Tian S; Wang F; Huang B; Tong Z; Tan S; Hao J; Wang Q; Tan W; Gao GF; Yan J
    Nat Commun; 2021 Apr; 12(1):2355. PubMed ID: 33859203
    [No Abstract]   [Full Text] [Related]  

  • 17. As Signals From the Kawasaki-Like Illness During the COVID-19 Pandemic: Is It Possible That the Incidence of IgA Nephropathy May Increase in the Future.
    Abdi Saed Y; Xu W; Yaigoub H; Tirichen H; Guo L; Cheng L; Li Y
    Front Med (Lausanne); 2021; 8():737692. PubMed ID: 34796184
    [No Abstract]   [Full Text] [Related]  

  • 18. Can lactoferrin boost human immunity against COVID-19?
    AlKhazindar M; Elnagdy SM
    Pathog Glob Health; 2020 Jul; 114(5):234-235. PubMed ID: 32529963
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic stumbling blocks in the COVID-19 monitoring of medical staff while putting hygiene requirements into practice.
    Schildgen V; Lüsebrink J; Thomaidis P; Meibert P; Schildgen O
    New Microbes New Infect; 2020 Sep; 37():100735. PubMed ID: 32834900
    [No Abstract]   [Full Text] [Related]  

  • 20. Research during SARS-CoV-2 pandemic: To "Preprint" or not to "Preprint", that is the question.
    Mayo-Yánez M
    Med Clin (Engl Ed); 2020 Jul; 155(2):86-87. PubMed ID: 32835097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.